May 04, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
A...
May 05, 2020: "The Joint European Disruptive Initiative is launching on a global basis the JEDI Billion Molecules against Covid19 Grand Challenge.
Stage...
May 5, 2020: "Topline data for a pivotal, single-arm, open-label trial for Sanofi and Regeneron’s PD-1 inhibitor Libtayo® (cemiplimab) in patients with advanced basal...
May 4, 2020: "Menarini Group announced a definitive agreement under which Menarini Group will acquire Stemline in a transaction valued up to $677 million.
Under the terms...
May 4, 2020: "The United States on Monday began requiring antibody tests for the new coronavirus to undergo a regulatory agency review, acknowledging that...
May 04, 2020: "The European Commission (EC) has approved a dosing and administration label update in the EU for AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) to include...
May 03, 2020: "Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its new Elecsys® Anti-SARS-CoV-2...
May 1, 2020: CDC has kicked off the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES) consortium, which will greatly expand the use...
May 01, 2020: "The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
Today,...
May 1, 2020: Gilead Sciences, Inc. announced that the U.S FDA has granted emergency use authorization (EUA) for the investigational antiviral remdesivir to treat COVID-19.
...
April 29, 2020: "Chimerix, a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases announced the Company’s...